MedPath

Patient-reported outcome measures (PROMs) in the assessment and follow-up monitoring of patients with depression in primary care

Not Applicable
Completed
Conditions
Topic: Mental Health, Primary Care
Subtopic: Depression, Mental Health, Primary care
Disease: Depression, All Diseases
Mental and Behavioural Disorders
Registration Number
ISRCTN97492541
Lead Sponsor
niversity of Southampton (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
48
Inclusion Criteria

Adults who are diagnosed with depression by their GPs

Exclusion Criteria

1. Patients with comorbid dementia, psychosis, or significant substance misuse, of a level that makes depression a secondary rather than primary diagnosis
2. Patients who are seriously suicidal and need urgent referral to secondary care

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcomes as of 15/12/2016:<br>1. Depressive symptoms are measured using the Beck Depression Inventory (BDI)-II at baseline, 12 weeks, and 26 weeks<br>2. Health-related quality of life is measured using the EuroQoL five-dimension scale (EQ-5D-DL) at baseline, 12 weeks, and 26 weeks<br>3. Social functioning is measured using the Work and Social Adjustment Scale (WSAS) at baseline, 12 weeks, and 26 weeks<br><br>Original primary outcome:<br>Beck Depression Inventory (BDI)-II; Timepoint(s): 12 weeks and 26 weeks
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes as of 15/12/2016:<br>1. Anxiety symptoms are measured using the GAD-7 screening questionnaire at baseline<br>2. Participant characteristic data is assessed using a bespoke demographic questionnaire at baseline<br>3. Previous history and treatment received by participant is assessed using a bespoke duration and past history of depression questionnaire at baseline<br>4. Details of use of health services by participant is assessed using a bespoke Client Services Receipt Inventory (CSRI) questionnaire at 26 weeks<br>5. Absence from work by participant is assessed using a bespoke Sickness Absence Questionnaire at 26 weeks<br>6. Satisfaction with GP consultations for depression is assessed using the Medical Informant Satisfaction Scale (MISS) at 26 weeks<br><br><br>Original secondary outcome:<br>1. EQ-5D; Timepoint(s): 12 weeks and 26 weeks<br>2. Short Form (SF)-12; Timepoint(s): 12 weeks and 26 weeks<br>3. Work and Social Adjustment Scale (WSAS); Timepoint(s): 12 weeks and 26 weeks
© Copyright 2025. All Rights Reserved by MedPath